Identification of patient venous thromboembolism risk across the continuum of care

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 6, 2011, Pages 590-599

  Caprini, Joseph A ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

anticoagulants; deep venous thrombosis; factor Xa inhibitors; low molecular weight heparins; pulmonary embolism; thrombosis prophylaxis

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; BED REST; CENTRAL VENOUS CATHETER; DEEP VEIN THROMBOSIS; GENDER; GLOMERULUS FILTRATION RATE; HORMONE SUBSTITUTION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; IMMOBILIZATION; KIDNEY FAILURE; LIVER FAILURE; LUNG EMBOLISM; NEOPLASM; OBESITY; PATIENT CARE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

FEMALE; HOSPITALIZATION; HUMANS; LONG-TERM CARE; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84857218767     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611404217     Document Type: Article

References (64)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed. Chest. 2008 ; 133 (6 suppl). 381S - 453S (Pubitemid 351894916)
2. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?. J R Soc Med. 1989 ; 82 (4). 203-205 (Pubitemid 19086881)
3. Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1968. Br J Surg. 1991 ; 78 (7). 849-852
4. Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001 ; 43: i-x, 1-668
5. Caprini JA, Hyers TM. Compliance with antithrombotic guidelines. Manag Care. 2006 ; 15 (9). 49-50, 53-60, 66
6. National Quality Forum. http://www.qualityforum.org/Measures-List.aspx. Accessed October 2010.
7. The Joint Commission. Performance Measurement Initiatives. Venous Thromboembolism (VTE) Core Measures Set - Last Updated 4/2009. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/ VTE.htm. Accessed October 2010.
8. Surgical Care Improvement Project (SCIP). http://www.cfmc.org/hospital/ hospital-scip.htm. Accessed October 2010
9. Anderson FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007 ; 82 (9). 777-782 (Pubitemid 350194504)
10. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000 ; 160 (6). 809-815 (Pubitemid 30165241)
11. NovelloACPatakiGE. State of New York Department of Health, Office of Health Systems Management, Division of Primary and Acute Care Services. New York Patient Occurrence Reporting and Tracking System Report. http://www.health. state.ny.us/nysdoh/hospital/nyports/annual-report/2002-2004/docs/ 2002-2004-nyports-annual-report.pdf. Accessed October 2010.
12. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996 ; 125 (1). 1-7
13. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002 ; 162 (10). 1144-1148 (Pubitemid 34522402)
14. Kahn SR. Frequency and determinants of the postthrombotic syndrome after venous thromboembolism. Curr Opin Pulm Med. 2006 ; 12 (5). 299-303 (Pubitemid 44315771)
15. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep venous thrombosis. J Thromb Haemost. 2008 ; 6 (7). 1105-1112 (Pubitemid 351859119)
16. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 ; 350 (22). 2257-2264
17. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000 ; 160 (6). 761-768 (Pubitemid 30165236)
18. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005 ; 352 (10). 969-977
19. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003 ; 107 (23 suppl 1). I9 - I16
20. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992 ; 305 (6853). 567-574
21. Borow M, Goldson H. Postoperative venous thrombosis. Evaluation of five methods of treatment. Am J Surg. 1981 ; 141 (2). 245-251 (Pubitemid 11183658)
22. Kröger K, Weiland D, Ose C, et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol. 2006 ; 17 (2). 297-303 (Pubitemid 43160121)
23. Donati MB. Cancer and thrombosis. Haemostasis. 1994 ; 24 (2). 128-131 (Pubitemid 24234490)
24. Sutherland DE, Weitz IC, Leibman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol. 2003 ; 72 (1). 43-52 (Pubitemid 36043750)
25. Wheeler HB. Diagnosis of deep vein thrombosis. Review of clinical evaluation and impedance plethysmography. Am J Surg. 1985 ; 150 (4A). 7-13 (Pubitemid 16191970)
26. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism: the Sixth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2001 ; 119 (1 suppl). 132S - 175S
27. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001 ; 38 (2 suppl 5). 12-19 (Pubitemid 32606834)
28. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefit of thromboprophylaxis in medical patients. Thromb Haemost. 2005 ; 94 (4). 750-759 (Pubitemid 41489233)
29. Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost. 2004 ; 2 (12). 2156-2161 (Pubitemid 40185776)
30. Seruya M, Venturi ML, Iorio ML, Davison SP. Efficacy and safety of venous thromboembolism prophylaxis in the highest risk plastic surgery patients. Plast Reconstr Surg. 2008 ; 122 (6). 1701-1708
31. Hatef DA, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008 ; 122 (1). 269-279
32. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010 ; 251 (2). 344-350
33. Panucci CJ, Bailey S, Fisher C, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. Presented at the 22nd Annual Meeting of the American Venous Forum ; Amelia Island, Florida, USA ;..
34. O'Shaughnessy D, Rose P, Pressley F, et al. Evaluating the performance of a previously reported risk score to predict venous thromboembolism: a VERITY registry study [abstract]. Blood. 2006 ; 108: 716
35. Kakkar VV. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet. 1975 ; 2 (7924). 45-51
36. Decousus H, Tapson VF, Bergmann JF, et al. Factors at Admission Associated with Bleeding Risk in Medical Patients: Findings from IMPROVE. Chest. 2011 ; 139 (1). 69-79
37. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost. 2005 ; 93 (1). 76-79 (Pubitemid 40124258)
38. Quinlan DJ, Eikelboom JW, Dahl OE, Eriksson BI, Sidhu PS, Hirsh J. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost. 2007 ; 5 (7). 1438-1443 (Pubitemid 46965372)
39. Cohen AT, Bailey CS, Alikhan R, Cooper DJ. Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty: a meta-analysis. Thromb Haemost. 2001 ; 85 (5). 940-941 (Pubitemid 32421835)
40. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet. 2001 ; 358 (9275). 9-15 (Pubitemid 32709732)
41. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001 ; 135 (10). 858-869 (Pubitemid 33070682)
42. Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized placebo-controlled double-blind study. Arch Intern Med. 2003 ; 163 (11). 1337-1342 (Pubitemid 36676199)
43. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988 ; 318 (18). 1162-1173
44. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007 ; 146 (4). 278-288 (Pubitemid 351650614)
45. Kidik PJ, Holbrook KF. The nurse practitioner role in evidence-based medication strategies. J Perianesth Nurs. 2008 ; 23 (2). 87-93
46. McMullin J, Cook D, Griffith L, et al. Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med. 2006 ; 34 (3). 694-699
47. Mahan CE, Spyropoulos AC. Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient. Hosp Pract. 2010 ; 38 (1). 97-108
48. Mosen D, Elliott CG, Egger MJ, et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest. 2004 ; 125 (5). 1635-1641 (Pubitemid 38648391)
49. Durieux P, Nizard R, Ravaud P, Mounier N, Lepage E. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA. 2000 ; 283 (21). 2816-2821 (Pubitemid 30387826)
50. Baroletti S, Munz K, Sonis J, et al. Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study. J Thromb Thrombolysis. 2008 ; 25 (2). 146-150
51. McLafferty RB, Lohr JM, Caprini JA, et al. Results of the national pilot screening program for venous disease by the American Venous Forum. J Vasc Surg. 2007 ; 45 (1). 142-148
52. Panucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini Risk Assessment Model in Plastic and Reconstructive Surgery Patients. J Am Coll Surg. 2011 ; 212 (1). 105-112
53. Spyropoulos AC. Risk assessment of venous thromboembolism in hospitalized medical patients. Curr Opin Pulm Med. 2010 ; 16 (5). 419-425
54. Spyropoulos AC, Anderson FA, Fitzgerald G, et al. Venous thromboembolism risk factors in acutely ill hospitalized medical patients: findings from the IMPROVE registry. J Thromb Hemost. 2009 ; 7 (suppl 2). 122
55. Arcelus JI, Monreal M, Caprini JA, et al. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost. 2008 ; 99 (3). 546-551 (Pubitemid 351549291)
56. Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost. 2009 ; 102 (5). 951-957
57. Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009 ; 339: b4583
58. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002 ; 346 (13). 975-980 (Pubitemid 34983247)
59. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006 ; 4 (11). 2384-2390 (Pubitemid 44575433)
60. Hull RD, Schellong SM, Tapson VF, et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med. 2010 ; 153 (1). 8-18
61. ClinicalTrials.gov, Trial No: NCT00457002 and NCT00571649. http://www.clinicaltrials.org. Accessed December 20, 2010
62. Panis LJ, Kolbach DN, Hamulyak K, Prins MH. Identifying inappropriate hospital stay in patients with venous thromboembolism. Eur J Intern Med. 2004 ; 15 (1). 39-44 (Pubitemid 38453041)
63. Leibson CL, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Risk factors for venous thromboembolism in nursing home residents. Mayo Clin Proc. 2008 ; 83 (2). 151-157 (Pubitemid 351303099)
64. Bosson JL, Labarere J, Sevestre MA, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med. 2003 ; 163 (21). 2613-2618 (Pubitemid 37464419)